• 1
    Okamura H, Tsutsui H, Komatsu T et al. Cloning of a new cytokine that induces interferon-γ production by T cells. Nature 1995; 378 : 88.
  • 2
    Dinarello CA, Novick D, Puren AJ et al. Overview of interleukin-18: more than an interferon-gamma inducing factor. J Leukoc Biol 1998; 63 : 658.
  • 3
    Puren AJ, Fantuzzi G, Gu Y, Su MS, Dinarello CA. Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells. J Clin Invest 1998; 101 : 711.
  • 4
    Olee T, Hashimoto S, Quach J, Lotz M. IL-18 is produced by articular chondrocytes and induces proinflammatory and catabolic responses. J Immunol 1999; 162 : 1096.
  • 5
    Matsumoto S, Tsuji-Takayama K, Aizawa Y, Koide K, Takeuchi M, Ohta T, Kurimoto M. Interleukin-18 activates NF-kappaB in murine T helper type 1 cells. Biochem Biophys Res Commun 1997; 234 : 454.
  • 6
    Netea MG, Fantuzzi G, Kullberg BJ et al. Neutralization of IL-18 reduces neutrophil tissue accumulation and protects mice against lethal Escherichia coli and Salmonella typhimurium endotoxemia. J Immunol 2000; 164 : 2644.
  • 7
    Joosten LA, Van De Loo FA, Lubberts E, Helsen MM, Netea MG, Van Der Meer JW, Dinarello CA, Van Den Berg WB. An IFN-gamma-independent proinflammatory role of IL-18 in murine streptococcal cell wall arthritis. J Immunol 2000; 165 : 6553.
  • 8
    Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994; 84 : 2068.
  • 9
    Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA. Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 1986; 137 : 245.
  • 10
    Marlin SD, Springer TA. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen (LFA-1). Cell 1987; 51 : 813.
  • 11
    Diamond MS, Staunton DE, De Fougerolles AR, Stacker SA, Garcia-Aguilar J, Hibbs ML, Springer TA. ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18). J Cell Biol 1990; 111 : 3129.
  • 12
    Novick D, Kim SH, Fantuzzi G, Reznikov LL, Dinarello CA, Rubinstein M. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 1999; 10 : 127.
  • 13
    Engelmann H, Aderka D, Rubinstein M, Rotman D, Wallach D. A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity. J Biol Chem 1989; 264 : 11974.
  • 14
    Keizer GD, Borst J, Figdor CG, Spits H, Miedema F, Terhorst C, De Vries JE. Biochemical and functional characteristics of the human leukocyte membrane antigen family LFA-1, Mo-1 and p150,95. Eur J Immunol 1985; 15 : 1142.
  • 15
    Andrew D, Shock A, Ball E, Ortlepp S, Bell J, Robinson M. KIM185, a monoclonal antibody to CD18 which induces a change in the conformation of CD18 and promotes both LFA-1- and CR3-dependent adhesion. Eur J Immunol 1993; 23 : 2217.
  • 16
    Caligaris-Cappio F, Pizzolo G, Chilosi M et al. Phorbol ester induces abnormal chronic lymphocytic leukemia cells to express features of hairy cell leukemia. Blood 1985; 66 : 1035.
  • 17
    Hemler ME, Sanchez-Madrid F, Flotte TJ, Krensky AM, Burakoff SJ, Bhan AK, Springer TA, Strominger JL. Glycoproteins of 210 000 and 130 000 m.w. on activated T cells: cell distribution and antigenic relation to components on resting cells and T cell lines. J Immunol 1984; 132 : 3011.
  • 18
    Sanchez-Madrid F, De Landazuri MO, Morago G, Cebrian M, Acevedo A, Bernabeu C. VLA-3: a novel polypeptide association within the VLA molecular complex: cell distribution and biochemical characterization. Eur J Immunol 1986; 16 : 1343.
  • 19
    Keizer GD, Te Velde AA, Schwarting R, Figdor CG, De Vries JE. Role of p150,95 in adhesion, migration, chemotaxis and phagocytosis of human monocytes. Eur J Immunol 1987; 17 : 1317.
  • 20
    Binnerts ME, Van Kooyk Y, Simmons DL, Figdor CG. Distinct binding of T lymphocytes to ICAM-1-2 or -3 upon activation of LFA-1. Eur J Immunol 1994; 24 : 2155.
  • 21
    De Fougerolles AR, Stacker SA, Schwarting R, Springer TA. Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1. J Exp Med 1991; 174 : 253.
  • 22
    Nelissen JM, Peters IM, De Grooth BG, Van Kooyk Y, Figdor CG. Dynamic regulation of activated leukocyte cell adhesion molecule- mediated homotypic cell adhesion through the actin cytoskeleton. Mol Biol Cell 2000; 11 : 2057.
  • 23
    Endres S, Ghorbani R, Lonnemann G, Van Der Meer JW, Dinarello CA. Measurement of immunoreactive interleukin-1 beta from human mononuclear cells. optimization of recovery, intrasubject consistency, and comparison with interleukin-1 alpha and tumor necrosis factor. Clin Immunol Immunopathol 1988; 49 : 424.
  • 24
    Drenth JP, Van Uum SH, Van Deuren M, Pesman GJ, Van der Ven-Jongekrijg J, Van der Meer JW. Endurance run increases circulating IL-6 and IL-1ra but downregulates ex vivo TNF-alpha and IL-1 beta production. J Appl Physiol 1995; 79 : 1497.
  • 25
    Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer 1980; 26 : 171.
  • 26
    Nagasawa K, Howatson A, Mak TW. Induction of human malignant T-lymphoblastic cell lines MOLT-3 and jurkat by 12-O-tetradecanoylphorbol-13-acetate. biochemical, physical, and morphological characterization. J Cell Physiol 1981; 109 : 181.
  • 27
    Kaplan J, Tilton J, Peterson Jr WD. Identification of T cell lymphoma tumor antigens on human T cell lines. Am J Hematol 1976; 1 : 219.
  • 28
    Kitching AR, Tipping PG, Kurimoto M, Holdsworth SR. IL-18 has IL-12-independent effects in delayed-type hypersensitivity: studies in cell-mediated crescentic glomerulonephritis. J Immunol 2000; 165 : 4649.
  • 29
    Morel JC, Park CC, Woods JM, Koch AE. A novel role for interleukin-18 in adhesion molecule induction through NF kappa B and phosphatidylinositol (PI) 3-kinase-dependent signal transduction pathways. J Biol Chem 2001; 276 : 37069.
  • 30
    Kohka H, Yoshino T, Iwagaki H et al. Interleukin-18/interferon-gamma-inducing factor, a novel cytokine, up-regulates ICAM-1 (CD54) expression in KG-1 cells. J Leukoc Biol 1998; 64 : 519.
  • 31
    Vidal-Vanaclocha F, Fantuzzi G, Mendoza L et al. IL-18 regulates IL-1beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1. Proc Natl Acad Sci USA 2000; 97 : 734.
  • 32
    Pober JS, Bevilacqua MP, Mendrick DL, Lapierre LA, Fiers W, Gimbrone MA Jr. Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells. J Immunol 1986; 136 : 1680.
  • 33
    Yoshida A, Takahashi HK, Nishibori M et al. IL-18-induced expression of intercellular adhesion molecule-1 in human monocytes. involvement in IL-12 and IFN-gamma production in PBMC. Cell Immunol 2001; 210 : 106.
  • 34
    Takei F. Inhibition of mixed lymphocyte response by a rat monoclonal antibody to a novel murine lymphocyte activation antigen (MALA-2). J Immunol 1985; 134 : 1403.
  • 35
    Beck-Schimmer B, Schimmer RC, Warner RL et al. Expression of lung vascular and airway ICAM-1 after exposure to bacterial lipopolysaccharide. Am J Respir Cell Mol Biol 1997; 17 : 344.
  • 36
    Fakler CR, Wu B, McMicken HW, Geske RS, Welty SE. Molecular mechanisms of lipopolysaccharide induced ICAM-1 expression in A549 cells. Inflamm Res 2000; 49 : 63.
  • 37
    Lee CH, Reid YA, Jong JS, Kang YH. Lipopolysaccharide-induced differential cell surface expression of intercellular adhesion molecule-1 in cultured human umbilical cord vein endothelial cells. Shock 1995; 3 : 96.